Requires health plan coverage to include certain generic drugs and biosimilars
REFERRED TO INSURANCE
Email me when A 11256 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 11256. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill forces New York health insurance policies to add any FDA‑approved generic drug or biosimilar that costs less than its brand counterpart to the plan’s formulary right away. Those drugs must be placed on a lower‑cost tier and cannot be blocked by prior authorization or step therapy, unless a clinical committee decides they are not appropriate. The change applies to policies issued after the law takes effect.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 11256
3 free questions a day, no accountHistory
- REFERRED TO INSURANCE
Sponsors
- Josh Jensen · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 11256 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 11256 freeOr ask your AI assistant about A 11256 directly:
Add to Claude, ChatGPT or Cursor